Cryopreservation Changes the Immune Effector Cell Composition of Peripheral Blood Stem Cell Grafts: An Analysis from the DKMS and NMDP Graft Composition Study
Elke Rücker‐Braun(University Hospital Carl Gustav Carus), Falk Heidenreich(University Hospital Carl Gustav Carus), Johannes Schetelig(University Hospital Carl Gustav Carus), Steven M. Devine(National Marrow Donor Program), Orla Maguire(Roswell Park Comprehensive Cancer Center), Bose Falk(Deutsche Knochenmarkspenderdatei), Martin Bornhäuser(Technische Universität Dresden), Alexander H. Schmidt(Deutsche Knochenmarkspenderdatei), Nicole Heymann(Deutsche Knochenmarkspenderdatei), Hugh R. MacMillan(Fred Hutch Cancer Center), Hans Minderman(Roswell Park Comprehensive Cancer Center), Deborah Buk(German National Bone Marrow Donor Registry), Heike Uhlemann(Deutsche Knochenmarkspenderdatei), Ashley Spahn(National Marrow Donor Program), Evan W. Newell(Agency for Science, Technology and Research), Stephen R. Spellman(National Marrow Donor Program), Kate A. Markey(Cornell University), Henning Baldauf(Deutsche Knochenmarkspenderdatei), Jeffery J. Auletta(Nationwide Children's Hospital), Kieran L. O’Loughlin(Roswell Park Comprehensive Cancer Center), Lisa Heiduschke(Deutsche Knochenmarkspenderdatei), Marcel R.M. van den Brink(City Of Hope National Medical Center)
Cited by 1
Related Papers
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
|New England Journal of Medicine|2012|1.2k